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Abbreviations
Sox9: Sex-determining Region on the Y Chromosome 
(SRY)-related High-Mobility Group (HMG) Box 9; PTHrP: 
Parathyroid hormone-related protein; Ihh: Indian hedgehog; 
FGFR: Fibroblast growth factor receptor; VEGF: Vascular 
endothelial growth factor; Cbfa1: Core binding factor alpha 
1; Runx2: Runt-related transcription factor 2; OPG/RANKL: 
Osteoprotegerin / Receptor activator of NF-kappaB ligand. 
Introduction
As functional appliances have been widely used for patients 
with growth potential, following questions are confronting 
orthodontists and researchers: What’s the fundamental 
mechanism of mandibular natural growth and growth 
modulation? What effects do functional appliances have 
on mandibular growth? Studies have been conducted on 
the development of the mandible with or without the use 
of functional appliance [1-4]. The effectiveness of the bite-
jumping appliance in the treatment of Class II malocclusion 
has been demonstrated by clinical cases [1]. Significant 
increase in the amount of condylar growth and in the overall 
length of mandible was observed in animals treated with 
mandibular forward appliances compared with those in control 
group [2]. Mandibular protrusion resulted in an increasing 
number of proliferative cells in the temporomandibular joint, 
which contributes to the development of the mandibular 
condyle and glenoid fossa [3]. However, it was claimed by 
others that functional appliances had no long-term impact 
on the pattern of mandibular growth although they would 
be capable of correcting discrepancies in molar relationship 
and overjet [4]. It has been demonstrated that the effects of 
functional appliances on mandibular growth can be attributed 
to independent components including condylar growth and 
mandibular total rotation [5-7]. This review will discuss the 
growth and modulation principle of mandible at molecular 
level from the perspective of condylar growth. 
The mandibular condylar cartilage serves as an important 
growth site of the mandible [8]. It is categorized as the 
secondary cartilage which is formed during phylogenesis and 
ontogenesis. It is different from the primary cartilage (such 
as the epiphyseal cartilage of long bones) which stems from 
the organism’s primary cartilaginous skeleton. The growth 
of primary cartilage is affected by general extrinsic factors, 
particularly by the growth hormone (STH) and somatomedin 
[9]. In this sense, orthopedic devices can only change the 
direction of its growth rather than the amount. On the contrary, 
the growth of condylar cartilage, the secondary cartilage, is 
subject to not only general factors like growth hormones but 
also local factors like mechanical force, thus can be modulated 
by appropriate orthopedic devices in both the direction and 
amount of its growth [10]. Several factors have been verified to 
have great impact on growth and development of mandibular 
condyle.
Sox9 and type II collagen
Mesenchymal cells in the proliferative layer of developing 
condyles differentiate into chondrocytes. It has been recognized 
that the transcription factor Sox9 [Sex-determining Region on the 
Y Chromosome (SRY)-related High-Mobility Group (HMG) 
Box 9] plays a key role in chondrocyte differentiation [11].
The function of Sox9 in chondrogenesis was not recognized 
until it was discovered that mutation in Sox9 could lead to 
Campomelic Dysplasia (CD), a rare human genetic disease 
characterized by the hypoplasia of most skeletal components 
generating from endochondral ossification [12,13]. Sox9 
is a transcription factor which consists of two domains: A 
DNA-binding domain and a transcriptional activator domain. 
The DNA binding domain contains a High Mobility Group 
(HMG) box which combines with specific sequence in the 
minor groove of DNA. Sox9 regulates chondrogenesis in two 
ways. Firstly, it is essential in the progress that mesenchymal 
cells differentiate into chondrocytes. It has been shown 
that, in mouse embryos, the Sox9 gene is expressed in all 
chondroprogenitor cells and at higher level in chondrocytes 
during chondrogenesis [14]. In Sox9 null cells of mouse 
chimeras, there’s no expression of chondrocyte-specific 
markers [15]. It is also found that misexpression of Sox9 in 
dermomyotome cells can make these cells deviate from their 
normal development path towards the cartilage differentiation 
program [16]. Secondly, Sox9 regulates condylar cartilage 
formation by modulating the expression of Col2a1 (Core 
binding factor alpha 1)-encoding type II collagen, the most 
abundant structural collagen component of cartilage, together 
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with other elements of cartilage-specific extracellular matrix 
(collagens IX, XI, the large proteoglycan aggrecan, etc.) 
[15,17]. Sox9 binds to and activates the 48-bp enhancer 
element of Col2a1 specific to chondrocytes [18]. If Sox9 
protein is truncated with the DNA binding domain retained 
and the transcriptional activator domain missing, enhancer 
activity of chondrocytes is shown to be inhibited [18].
Rabie and Hӓgg found that during natural growth of rats’ 
condyles, Sox9 was expressed in mesenchymal cells and 
chondrocytes, indicating its similar effects on regulating 
mesenchymal cells differentiation and cartilage formation 
[19]. When the mandible is positioned forward, there is an 
up-regulation of the expression of Sox9 as well as type II 
collagen in the condyle and the glenoid fossa, resulting in an 
increased amount of cartilage formation and subsequent new 
bone deposition [20,21]. 
Parathyroid hormone-related protein (PTHrP)
There has been a growing interest in the regulatory 
effects of parathyroid hormone-related protein (PTHrP) on 
proliferation and differentiation of chondrocytes. The impact 
of PTHrP deficiency varied greatly between the craniofacial 
cartilages, according to the distinct features of each cartilage 
[22]. 
There was a significant reduction in the number 
of proliferative chondrocytes in condylar cartilage of 
homozygous PTHrP-knockout mice [23]. A significant 
reduction of the hypertrophic-chondrocyte-specific type X 
collagen was also detected in the PTHrP-knockout group 
when compared with wild-type group [23]. 
It is hypothesized that Sox9 is a target for PTHrP 
signaling [24,25]. PTHrP was observed to up-regulate Sox9, 
the factor regulating the differentiation of mesenchymal cells 
into chondroblasts. Therefore, it is suggested that PTHrP 
may induce the differentiation of mesenchymal cells through 
the Sox9 pathway. PTHrP may enhance the transcriptional 
activity of Sox9, facilitating the maintenance of the phenotype 
of chondrocytes in the pre-hypertrophic zone and hampers 
their differentiation into hypertrophic chondrocytes [24,25].
It was found that forward positioning of mandible triggered 
the expression of PTHrP, which led to an increased number 
of differentiated chondroblasts and meanwhile a retardation 
of chondrocyte hypertrophy, followed by increased cartilage 
volume. Therefore, through functional appliance therapy, 
the condyle is endowed with more potential to construct the 
cartilage frame for future endochondral bone deposition [26].
Indian hedgehog (Ihh)
It has been identified that Indian hedgehog (Ihh), a member 
of the hedgehog (Hh) family, plays a key role in proliferation, 
hypertrophy and apoptosis of chondrocytes. A more severe 
dwarfism was shown in Ihh null mice compared with PTHrP-
deficiency mice, suggesting that Ihh acts upon growth plate 
through pathways both dependent and independent of PTHrP 
and its receptor [27]. On the one hand, it regulates chondrocytes 
proliferation in the proliferative zone by independent 
mechanisms. It has been found that in Ihh-deficiency neonatal 
mice that condylar growth and organization is hindered due 
to reduced polymorphic cell layer proliferation and changed 
fibrocartilaginous nature. Meanwhile, an extremely low level 
of PTHrP is detected in both the Ihh-deficiency and wild-
type group, indicating that Ihh may act directly on progenitor 
cells by long-range diffusion from its site of origin [28]. This 
hypothesis has been supported by the observation that there is 
a strong expression of hedgehog target gene in polymorphic 
layer [29]. On the other hand, Ihh maintains the pool of 
proliferative chondrocytes in the growth plate via stimulating 
PTHrP synthesis by cells in the periarticular perichondrium. 
Increased signaling through the PTHrP receptor leads to 
delayed process of chondrocyte hypertrophy and expanded 
pool of proliferating cells, and vice visa [27]. Studies have 
demonstrated that in Ihh-deficiency mouse embryos, PTHrP 
expression and chondrocytes proliferation in mandibular 
condyle is inhibited [29]. It is recognized that Ihh and PTHrP 
are key elements of a feedback loop which controls the relative 
proportions of proliferating and hypertrophic chondrocytes in 
growth plates [30]. 
Tang et al. [31] found that mandibular advancement 
stimulated the expression of Ihh in condylar cartilage resulting 
in an increased number of proliferating mesenchymal cells 
and a shortened turnover time. Their findings suggest that Ihh 
may mediate the conversion process of the mechanical signals 
caused by mandibular advancement into cellular replication 
in condylar cartilage [31].
Fibroblast growth factor (FGF) and its receptors (FGFRs)
As members of the tyrosine-kinase receptor family, the 
fibroblast growth factor receptors (FGFRs) are known to 
have a significant impact on the growth and development of 
cartilaginous tissues [32]. 
In mandibular condyle, chondroblasts and hypertrophic 
chondrocytes showed the most pronounced immunoreactivity 
for receptors of FGF-2, including FGFR1 and FGFR3. 
However, immunoreactivity for FGFR2 was found to be 
strongest in the articular and prechondroblastic zones, 
indicating that FGF-2 may to some extent, modulate the 
proliferation activity in condylar cartilage [33]. 
Designed to create a lateral functional shift of the mandible, 
intraoral appliances bring about a transverse rotation of the 
mandible with the condyle on the shifting side remaining in 
place or moving slightly posteriorly (non-protruded) while 
the opposite site distracted anteriorly (protruded) from the 
glenoid fossa. There were significant differences in gene 
expression for FGF-2, FGFR1, FGFR2 and FGFR3 between 
the protruded and non-protruded condylar cartilage [34]. The 
changes in gene expression of FGF-2 and its receptors were 
suggested to be partly responsible for proliferative activity 
alterations in condylar cartilage after mandibular shift [34]. 
Type X collagen
Chondrocytes mature after cartilage matrix has been formed. 
Subsequently, endochondral bone deposition and replacement 
of cartilage matrix take place. Type X collagen, secreted by 
hypertrophic chondrocytes, is recognized as an indicator 
for endochondral ossification and bone replacement of the 
cartilage matrix [35]. 
Type X collagen is a homotrimeric molecule which 
belongs to the short chain collagen family [30]. It has been 
proved at mRNA and protein levels that the expression 
of type X collagen is spatiotemporally correlated with 
endochondral ossification. Spatially, it is detected that type 
X collagen initially appears throughout the hypertrophic 
zone when chondrocytes mature, whereas it is missing from 
the proliferative zone [36].  Therefore, it is considered as a 
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unique element of the hypertrophic cartilage matrix and a 
critical marker for endochondral bone formation [30,37]. 
Temporally, the expression of the type X collagen gene 
precedes endochondral bone formation [38]. In vitro studies 
show that its expression takes place before bone deposition by 
cultured chondrocytes as well [39].
When the mandible is positioned forward by functional 
appliances, intensive expression of type X collagen is 
found to distribute throughout the hypertrophic zone when 
compared with the controls, indicating the onset of condylar 
endochondral bone formation stimulated by the functional 
appliances therapy [40]. In addition, Mastication forces 
also seem to stimulate type X collagen synthesis and bone 
deposition [41]. 
Vascular endothelial growth factor (VEGF)
Osteogenesis (bone formation) is closely associated with 
angiogenesis (blood vessels invasion) [42]. The invading 
blood vessels bring osteogenic progenitor mesenchymal cells 
into the mineralization front. These cells later differentiate into 
osteoblasts and engage in osteogenesis. Vascular Endothelial 
Growth Factor (VEGF) is known to be a potent regulator of 
neovascularization [42,43].
VEGF is a dimeric glycoprotein, with a molecular mass 
ranging from 17 to 22 kDa [44]. It is an endothelial cell 
mitogen and inducer of angiogenesis and microvascular 
permeability. It was found that VEGF was uniquely produced 
by hypertrophic chondrocytes immediately before vascular 
invasion, instead of quiescent or proliferating chondrocytes in 
avian and mammalian embryo long bones [45]. 
Both in vivo and in vitro studies show that VEGF receptor 2 
can co-localize with the factor in hypertrophic cartilage, which 
suggests that there may be an autocrine loop in chondrocytes 
as they mature and hypertrophy. Antibodies against VEGF 
or VEGF receptor 2 inhibit endothelial cell migration, which 
indicates VEGF’s critical role in neovascularization of 
hypertrophic cartilage through a paracrine release targeting 
at invading endothelial cells [45]. Numerous small blood 
vessels and vascular structures are found to distribute 
in the subchondral region where VEGF shows maximal 
expression [46]. Furthermore, VEGF plays a key role in the 
replacement of cartilage by bone during growth and repair 
through angiogenesis. Horner et al. observed co-localized 
expression of VEGF with alkaline phosphatase in modeling 
and remodeling sites [47]. When VEGF was inactivated by a 
soluble receptor chimeric protein systematically administered 
in mice, blood vessel invasion was almost completely 
suppressed. Meanwhile, trabecular bone formation is 
hampered accompanied by expansion of hypertrophic 
chondrocyte zone [48]. Therefore, it is suggested that VEGF 
may also play an important role in regulating endochondral 
ossification in condyles by controlling neovascularization.
Upon forward mandibular positioning by bite-jumping 
appliance, there was a significant up-regulation of VEGF, 
followed by accelerated vascularization and subsequently 
increased new bone formation in both the condyle and 
glenoid fossa [49,50]. It was found that the temporal 
expression of VEGF was correlated with the pattern of 
new bone formation in condyle and glenoid fossa during 
stepwise mandibular advancement [51,52]. In comparison 
with one-step advancement, the initial advancement in the 
stepwise group demonstrated significantly less expression 
of VEGF. However, VEGF expression appeared to increase 
significantly in the stepwise group when compared with the 
single advancement group and the natural growth group. 
This result suggests that the mechanical stimuli provided by 
stepwise mandibular advancement may trigger a sequence of 
cellular events resulting in increased vascularization and bone 
deposition in condyle [51,52]. 
Core binding factor alpha 1 (Cbfa1)/ Runt-related 
transcription factor 2 (Runx2)
Core binding factor alpha 1 (Cbfa1), also known as Runt-
related transcription factor 2 (Runx2), has been confirmed to 
serve as a key regulator of condylar cartilage development, 
osteoblast differentiation and bone matrix deposition [53-56].
It is demonstrated that Cbfa1/Runx2 functions uniquely 
in the development of mandibular condyle cartilage when 
compared with in the primary cartilage. Studies have shown 
that in Runx2-deficient mice, the primary cartilage is not 
significantly affected while the mandibular cartilage is 
completely disappeared, suggesting a distinct regulatory 
effect of Cbfa1/Runx2 possibly due to the periosteal origin of 
condylar cartilage [53,54,56]. Osteoblasts, which function as 
bone making cells, differentiate from progenitor mesenchymal 
cells brought by invading blood vessels. Cbfa1/Runx2 is an 
indispensable factor for osteoblast differentiation and bone 
deposition during endochondral ossification [53,54]. Cbfa1/
Runx2 is targeted to the promoters of several bone proteins, 
including osteocalcin (an osteoblast-specific marker), bone 
sialoprotein, alkaline phosphatase, and type I collagen [53]. 
It has been shown that in homozygous Cbfa1/Runx2-deficient 
mice, no bone tissue is developed even with the existence of 
a relatively normal cartilage skeleton [53]. Besides, Cbfa1/
Runx2 regulates chondrocyte maturation and hypertrophy 
during endochondral ossification. Rabie et al. found that 
during the natural development of mandibular condyle, 
the peaking of Cbfa1 level coincides with chondrocyte 
hypertrophy and matrix mineralization [57]. It has also been 
shown that mandibular advancement triggers Cbfa1/Runx2 
expression in condylar cartilage, resulting in increased 
osteoblasts invasion and stimulated chondrocyte terminal 
maturation [58]. Cbfa1/Runx2 is also related to the expression 
of VEGF and angiogenesis. In homozygous Cbfa1 null mice, 
there are no blood vessels growing into cartilage, even if 
chondrocyte hypertrophy occurs [54]. Overall, Cbfa1/Runx2 
couples the process of chondrocytes maturation, bone matrix 
mineralization as well as osteoblasts differentiation during 
endochondral ossification. 
Osteoprotegerin (OPG) / Receptor activator of NF-
kappaB ligand (RANKL)
It is found that receptor activator of NF-kappaB ligand 
(RANKL) which belongs to the tumor necrosis factor 
superfamily together with osteoprotegerin (OPG), its decoy 
receptor, plays a crucial role in coordinating between 
osteoblasts and osteoclasts, providing deeper insights 
into development, turnover and maintenance of bone [59-
62]. Osteoclasts carry out the key function of resorbing 
the mineralized hypertrophic cartilage and facilitating the 
deposition of osteoblasts to structure the bone matrix. It has 
been recognized that the ratio of OPG/RANKL plays a major 
role in the regulation of osteoclastogenesis: an increased ratio 
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leads to a reduced number of newly formed osteoclasts and 
vice versa [59]. It was suggested that altered functional loading 
in temporomandibular joint of mice may lead to an increase in 
the OPG/RANKL ratio and a subsequent suppression of the 
formation of osteoclasts, resulting in a return of bone density 
to the baseline level after a transient decrease [60]. 
Other studies disclosed that there was an obvious 
subchondral bone loss following cartilage degradation 
in rat model with OA (Osteoarthritis)-like lesions in the 
mandibular condyle. Meanwhile, a decrease of chondrocytes-
secreted OPG/RANKL ratio and decrease of OPG level was 
observed, suggesting its critical role in the osteoclastogenesis 
of mandibular condyle [61]. However, a more detailed 
illustration of functional appliances’ effects on endochondral 
ossification in mandibular condyle achieved by coordination 
between osteoblasts and osteoclasts still needs to be obtained 
with the introduction of OPG and RANKL.
Summary
A series of events are engaged in the process of condylar 
growth. Initially, Sox9 transcription factor is expressed 
in the proliferative layer facilitating the differentiation of 
mesenchymal cells into chondroblasts. Meanwhile, PTHrP 
stimulates the differentiation of mesenchymal cells through the 
Sox9 pathway. FGF and its receptors may also regulate in part 
the proliferation activity in the mandibular condylar cartilage. 
Next, chondroblasts synthesize the Type II collagen, marking 
the onset of cartilage formation. This process is also modulated 
by Sox9 transcription factor. Chondrocytes proceed to mature 
and hypertrophy. Hypertrophic chondrocytes generate type 
X collagen which constitutes the framework of hypertrophic 
cartilage destined for bone deposition. In the whole process of 
cartilage formation, Ihh modulates chondrocyte proliferation, 
hypertrophy and apoptosis through pathways both dependent 
and independent of PTHrP and its receptor. VEGF is secreted 
in the hypertrophic cartilage, regulating neovascularization 
and replacement of cartilage matrix with bone. Bone 
marrow and resorptive tissue are formed with degradation of 
hypertrophic cartilage. Osteogenic progenitor mesenchymal 
cells are brought by invading blood vessels to the cartilage 
matrix and later differentiate into osteoblasts responsible 
for osteogenesis. During endochondral ossification, Cbfa1 
is essential in regulating maturation of chondrocyte and 
differentiation of osteoblasts. OPG and RANKL contribute to 
osteogenesis directly by communicating between osteoblasts 
and osteoclasts. 
It has been proved that mandibular position forwarding 
by bite-jumping appliance can stimulate mandibular condylar 
growth by regulating the expression of Sox9, type II collagen, 
type X collagen at both mRNA and protein levels and VEGF, 
PTHrP, Ihh at protein level. Further research is expected to 
explore the gene expressions of these regulatory factors under 
various circumstances, and to explain the communication 
between cartilage and bone.
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